Somatic hypermutation and VH gene usage in hairy cell leukaemia
Evgeny Arons
Clinical Immunotherapy Section, Laboratory of Molecular Biology, Centers for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Search for more papers by this authorJoel Sunshine
Clinical Immunotherapy Section, Laboratory of Molecular Biology, Centers for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Search for more papers by this authorTara Suntum
Clinical Immunotherapy Section, Laboratory of Molecular Biology, Centers for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Search for more papers by this authorRobert J. Kreitman
Clinical Immunotherapy Section, Laboratory of Molecular Biology, Centers for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Search for more papers by this authorEvgeny Arons
Clinical Immunotherapy Section, Laboratory of Molecular Biology, Centers for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Search for more papers by this authorJoel Sunshine
Clinical Immunotherapy Section, Laboratory of Molecular Biology, Centers for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Search for more papers by this authorTara Suntum
Clinical Immunotherapy Section, Laboratory of Molecular Biology, Centers for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Search for more papers by this authorRobert J. Kreitman
Clinical Immunotherapy Section, Laboratory of Molecular Biology, Centers for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
Search for more papers by this authorSummary
To examine the usage and mutational status of VH genes in hairy cell leukaemia (HCL), we analysed 24 immunoglobulin heavy chain (IgH) sequences expressed in 23 patients. None had premature stop codons. VH3-23 was the most common gene and a VH6 gene was observed for the first time in HCL. Although the mean mutation frequency was 6·1%, slightly higher than in previous HCL series, four patients had 99·6–100% homology to germline sequences, three of whom had high tumour burdens and poor outcomes. Despite the high mutation frequency, only two of 24 rearrangements had clear statistical evidence of antigen-dependent somatic mutation. Our results increase the database of reported functional HCL rearrangements to 94 in 92 patients. Overall, both gene usage and mutation frequency are very similar to mucosa-associated lymphoid tissue-type marginal zone lymphoma. The data are consistent with HCL originating from post-germinal centre marginal zone B cells, although the heterogeneity observed suggests that HCL may originate differently in some patients, and this could have implications for prognosis and treatment.
References
- Anderson, K.C., Boyd, A.W., Fisher, D.C., Leslie, D., Schlossman, S.F. & Nadler, L.M. (1985) Hairy cell leukemia: a tumor of pre-plasma cells. Blood, 65, 620–629.
- Bethel, K.J. & Sharpe, R.W. (2003) Pathology of hairy-cell leukaemia. Best Practice & Research Clinical Haematology, 16, 15–31.
- Brezinschek, H.P., Foster, S.J., Brezinschek, R.I., Dorner, T., Domiati-Saad, R. & Lipsky, P.E. (1997) Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(−)/IgM+ B cells. Journal of Clinical Investigation, 99, 2488–2501.
- Casali, P. & Schettino, E.W. (1996) Structure and function of natural antibodies. Current Topics in Microbiology and Immunology, 210, 167–179.
- Chang, B. & Casali, P. (1994) The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunology Today, 15, 367–373.
- Cook, G.P., Tomlinson, I.M., Walter, G., Riethman, H., Carter, N.P., Buluwela, L., Winter, G. & Rabbitts, T.H. (1994) A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q. Nature Genetics, 7, 162–168.
- Damle, R.N., Wasil, T., Fais, F., Ghiotto, F., Valetto, A., Allen, S.L., Buchbinder, A., Budman, D., Dittmar, K., Kolitz, J., Lichtman, S.M., Schulman, P., Vinciguerra, V.P., Rai, K.R., Ferrarini, M. & Chiorazzi, N. (1999) Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood, 94, 1840–1847.
- Davi, F., Maloum, K., Michel, A., Pritsch, O., Magnac, C., Macintyre, E., Salomon-Nguyen, F., Binet, J.L., Dighiero, G. & Merle-Beral, H. (1996) High frequency of somatic mutations in the VH genes expressed in prolymphocytic leukemia. Blood, 88, 3953–3961.
- Van Dongen, J.J., Langerak, A.W., Bruggemann, M., Evans, P.A., Hummel, M., Lavender, F.L., Delabesse, E., Davi, F., Schuuring, E., Garcia-Sanz, R., Van Krieken, J.H., Droese, J., Gonzalez, D., Bastard, C., White, H.E., Spaargaren, M., Gonzalez, M., Parreira, A., Smith, J.L., Morgan, G.J., Kneba, M. & Macintyre, E.A. (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98–3936. Leukemia, 17, 2257–2317.
-
Dorner, T.,
Foster, S.J.,
Farner, N.L. &
Lipsky, P.E. (1998) Somatic hypermutation of human immunoglobulin heavy chain genes: targeting of RGYW motifs on both DNA strands.
European Journal of Immunology, 28, 3384–3396.
10.1002/(SICI)1521-4141(199810)28:10<3384::AID-IMMU3384>3.0.CO;2-T CAS PubMed Web of Science® Google Scholar
- Dunn-Walters, D.K., Boursier, L., Spencer, J. & Isaacson, P.G. (1998) Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation. Human Pathology, 29, 585–593.
- Falini, B., Schwarting, R., Erber, W., Posnett, D.N., Martelli, M.F., Grignani, F., Zuccaccia, M., Gatter, K.C., Cernetti, C., Stein, H. & Mason, D.Y. (1985) The differential diagnosis of hairy cell leukemia with a panel of monoclonal antibodies. American Journal of Clinical Pathology, 83, 289–300.
- Forconi, F., Sahota, S.S., Raspadori, D., Mockridge, C.I., Lauria, F. & Stevenson, F.K. (2001) Tumor cells of hairy cell leukemia express multiple clonally related immunoglobulin isotypes via RNA splicing. Blood, 98, 1174–1181.
- Golde, D.W., Stevens, R.H., Quan, S.G. & Saxon, A. (1977) Immunoglobulin synthesis in hairy cell leukaemia. British Journal of Haematology, 35, 359–365.
- Golomb, H.M., Catovsky, D. & Golde, D.W. (1978) Hairy cell leukemia: a clinical review based on 71 cases. Annals of Internal Medicine, 89, 677–683.
- Hamblin, T.J., Davis, Z., Gardiner, A., Oscier, D.G. & Stevenson, F.K. (1999) Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 1848–1854.
- Ichihara, Y., Matsuoka, H. & Kurosawa, Y. (1988) Organization of human immunoglobulin heavy chain diversity gene loci. EMBO Journal, 7, 4141–4150.
- Insel, R.A., Varade, W.S., Chu, Y.W., Marin, E., Fuleihan, R. & Geha, R.S. (1995) Somatic mutation of human immunoglobulin V genes: bias, rate, and regulation. Annals of the New York Academy of Sciences, 764, 158–169.
- Jansen, J., Schuit, H.R., Meijer, C.J., Van Nieuwkoop, J.A. & Hijmans, W. (1982) Cell markers in hairy cell leukemia studied in cells from 51 patients. Blood, 59, 52–60.
- Jukes, T.H. & King, J.L. (1979) Evolutionary nucleotide replacements in DNA. Nature, 281, 605–606.
- Kuppers, R., Klein, U., Hansmann, M.L. & Rajewsky, K. (1999) Cellular origin of human B-cell lymphomas. New England Journal of Medicine, 341, 1520–1529.
- Lossos, I.S., Tibshirani, R., Narasimhan, B. & Levy, R. (2000) The inference of antigen selection on Ig genes. Journal of Immunology, 165, 5122–5126.
- Maloum, K., Magnac, C., Azgui, Z., Cau, C., Charlotte, F., Binet, J.L., Merle-Beral, H. & Dighiero, G. (1998) VH gene expression in hairy cell leukaemia. British Journal of Haematology, 101, 171–178.
- Matutes, E., Morilla, R., Owusu-Ankomah, K., Houliham, A., Meeus, P. & Catovsky, D. (1994a) The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leukemia and Lymphoma, 14 (Suppl. 1), 57–61.
- Matutes, E., Morilla, R., Owusu-Ankomah, K., Houlihan, A. & Catovsky, D. (1994b) The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders. Blood, 83, 1558–1562.
- Matutes, E., Owusu-Ankomah, K., Morilla, R., Garcia Marco, J., Houlihan, A., Que, T.H. & Catovsky, D. (1994c) The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia, 8, 1640–1645.
- Messmer, B.T., Sullivan, J.J., Chiorazzi, N., Rodman, T.C. & Thaler, D.S. (1999) Two human neonatal IgM antibodies encoded by different variable-region genes bind the same linear peptide: evidence for a stereotyped repertoire of epitope recognition. Journal of Immunology, 162, 2184–2192.
- Miranda, R.N., Cousar, J.B., Hammer, R.D., Collins, R.D. & Vnencak-Jones, C.L. (1999) Somatic mutation analysis of IgH variable regions reveals that tumor cells of most parafollicular (monocytoid) B-cell lymphoma, splenic marginal zone B-cell lymphoma, and some hairy cell leukemia are composed of memory B lymphocytes. Human Pathology, 30, 306–312.
- Muramatsu, M., Kinoshita, K., Fagarasan, S., Yamada, S., Shinkai, Y. & Honjo, T. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell, 102, 553–563.
- Oscier, D.G., Gardiner, A.C., Mould, S.J., Glide, S., Davis, Z.A., Ibbotson, R.E., Corcoran, M.M., Chapman, R.M., Thomas, P.W., Copplestone, J.A., Orchard, J.A. & Hamblin, T.J. (2002) Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood, 100, 1177–1184.
- Polliack, A. (2002) Hairy cell leukemia: biology, clinical diagnosis, unusual manifestations and associated disorders. Reviews in Clinical and Experimental Hematology, 6, 366–388; discussion 449–450.
- Radic, M.Z. & Weigert, M. (1994) Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annual Review of Immunology, 12, 487–520.
- Robbins, B.A., Ellison, D.J., Spinosa, J.C., Carey, C.A., Lukes, R.J., Poppema, S., Saven, A. & Piro, L.D. (1993) Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood, 82, 1277–1287.
- Rogozin, I.B. & Diaz, M. (2004) Cutting edge: DGYW/WRCH is a better predictor of mutability at G:C bases in Ig hypermutation than the widely accepted RGYW/WRCY motif and probably reflects a two-step activation-induced cytidine deaminase-triggered process. Journal of Immunology, 172, 3382–3384.
- Rosenquist, R., Lindstrom, A., Holmberg, D., Lindh, J. & Roos, G. (1999) V(H) gene family utilization in different B-cell lymphoma subgroups. European Journal of Haematology, 62, 123–128.
- Sanz, I., Kelly, P., Williams, C., Scholl, S., Tucker, P. & Capra, J.D. (1989) The smaller human VH gene families display remarkably little polymorphism. EMBO Journal, 8, 3741–3748.
- Stevenson, F.K., Sahota, S.S., Ottensmeier, C.H., Zhu, D., Forconi, F. & Hamblin, T.J. (2001) The occurrence and significance of V gene mutations in B cell-derived human malignancy. Advances in Cancer Research, 83, 81–116.
- Thorselius, M., Walsh, S.H., Thunberg, U., Hagberg, H., Sundstrom, C. & Rosenquist, R. (2005a) Heterogeneous somatic hypermutation status confounds the cell of origin in hairy cell leukemia. Leukemia Research, 29, 153–158.
- Thorselius, M., Krober, A., Murray, F., Thunberg, U., Tobin, G., Buhler, A., Kienle, D., Albesiano, E., Maffei, R., Dao-Ung, L.P., Wiley, J., Vilpo, J., Laurell, A., Merup, M., Roos, G., Karlsson, K., Chiorazzi, N., Marasca, R., Dohner, H., Stilgenbauer, S. & Rosenquist, R. (2005b) Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3–21-utilizing chronic lymphocytic leukemia independent of geographical origin and mutational status. Blood, 29 November [Epub ahead of print].
- Thunberg, U., Johnson, A., Roos, G., Thorn, I., Tobin, G., Sallstrom, J., Sundstrom, C. & Rosenquist, R. (2001) CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia. Blood, 97, 1892–1894.
- Tierens, A., Delabie, J., Malecka, A., Wang, J., Gruszka-Westwood, A., Catovsky, D. & Matutes, E. (2003) Splenic marginal zone lymphoma with villous lymphocytes shows on-going immunoglobulin gene mutations. American Journal of Pathology, 162, 681–689.
- Tobin, G., Thunberg, U., Karlsson, K., Murray, F., Laurell, A., Willander, K., Enblad, G., Merup, M., Vilpo, J., Juliusson, G., Sundstrom, C., Soderberg, O., Roos, G. & Rosenquist, R. (2004) Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. Blood, 104, 2879–2885.
- Vanhentenrijk, V., Tierens, A., Wlodarska, I., Verhoef, G. & Wolf-Peeters, C.D. (2004) V(H) gene analysis of hairy cell leukemia reveals a homogeneous mutation status and suggests its marginal zone B-cell origin. Leukemia, 18, 1729–1732.
- Varade, W., Marin, E., Milano, M., Insel, R., Swerdlow, S. & Williams, M. (1995) VH gene repertoire of mantle cell lymphomas. Annals of the New York Academy of Sciences, 764, 504–506.
- Wagner, S.D., Martinelli, V. & Luzzatto, L. (1994) Similar patterns of V kappa gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia, and myeloma. Blood, 83, 3647–3653.
- Wu, T.T., Johnson, G. & Kabat, E.A. (1993) Length distribution of CDRH3 in antibodies. Proteins, 16, 1–7.
- Yamada, M., Wasserman, R., Reichard, B.A., Shane, S., Caton, A.J. & Rovera, G. (1991) Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. Journal of Experimental Medicine, 173, 395–407.
- Zemlin, M., Klinger, M., Link, J., Zemlin, C., Bauer, K., Engler, J.A., Schroeder, Jr, H.W. & Kirkham, P.M. (2003) Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. Journal of Molecular Biology, 334, 733–749.
- Zhu, D., Oscier, D.G. & Stevenson, F.K. (1995) Splenic lymphoma with villous lymphocytes involves B cells with extensively mutated Ig heavy chain variable region genes. Blood, 85, 1603–1607.
- Zhu, D., Thompsett, A.R., Bedu-Addo, G., Stevenson, F.K. & Bates, I. (1999) VH gene sequences from a novel tropical splenic lymphoma reveal a naive B cell as the cell of origin. British Journal of Haematology, 107, 114–120.